Actionable insights straight to your inbox

Equities logo

Sorrento To Present Positive Data on Arthritis and Cancer Pain Drug; Rejects Latest Acquisition Bid

Data to be presented at AAPM in March 2020 and OARSI in May 2020. Latest $7/share bid rejected.